Isoginkgetin antagonizes ALS pathologies in its animal and patient iPSC models via PINK1-Parkin-dependent mitophagy.
- DOI
- 10.1038/s44321-025-00323-2
- Published
- 2025 Nov
- Container
- EMBO molecular medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s44321-025-00323-2,
title = {Isoginkgetin antagonizes ALS pathologies in its animal and patient iPSC models via PINK1-Parkin-dependent mitophagy.},
author = {Li A and Huang S and Cao SQ and Lin J and Zhao L and Yu F and Huang M and Yang L and Xin J and Wen J and Yan L and Zhang K and Jiang M and Le W and Li P and Liu YU and Qin D and Lu J and Lu G and Shen H and Yao X and Fang EF and Su H},
year = {2025},
journal = {EMBO molecular medicine},
doi = {10.1038/s44321-025-00323-2},
url = {https://doi.org/10.1038/s44321-025-00323-2}
}RIS
TY - JOUR TI - Isoginkgetin antagonizes ALS pathologies in its animal and patient iPSC models via PINK1-Parkin-dependent mitophagy. AU - Li A AU - Huang S AU - Cao SQ AU - Lin J AU - Zhao L AU - Yu F AU - Huang M AU - Yang L AU - Xin J AU - Wen J AU - Yan L AU - Zhang K AU - Jiang M AU - Le W AU - Li P AU - Liu YU AU - Qin D AU - Lu J AU - Lu G AU - Shen H AU - Yao X AU - Fang EF AU - Su H PY - 2025 JO - EMBO molecular medicine DO - 10.1038/s44321-025-00323-2 UR - https://doi.org/10.1038/s44321-025-00323-2 ER -
APA
A, L., S, H., SQ, C., J, L., L, Z., F, Y., M, H., L, Y., J, X., J, W., L, Y., K, Z., M, J., W, L., P, L., YU, L., D, Q., J, L., G, L., H, S., X, Y., EF, F., & H, S. (2025). Isoginkgetin antagonizes ALS pathologies in its animal and patient iPSC models via PINK1-Parkin-dependent mitophagy.. EMBO molecular medicine. https://doi.org/10.1038/s44321-025-00323-2
Source records
- pubmed · retrieved 2026-09-26T15:18:59.285Z